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Human T-cell leukemia virus type 1 (HTLV-1) causes
adult T-cell leukemia (ATL). Specific therapeutic and
prophylactic agents are not available. Epidemiological
studies have established a correlation between long-term
use of the commonly prescribed anti-diabetic drug met-
formin and a decrease in the incidence of breast and
other cancers. Whether metformin might also have anti-
HTLV-1 and anti-ATL activity is unclear. In this study
we demonstrate an inhibitory effect of metformin on
HTLV-1 transcription mediated through the activation
of LKB1 tumor suppressor and downstream salt-induci-
ble kinases (SIKs). Treatment of HTLV-1- transformed
ATL cells or cells transfected with HTLV-1 molecular
clone pX1MT with metformin led to reduction in cell-
free virion production and inhibition of cell prolifera-
tion. This effect was attributed to the activation of
LKB1/SIK1 which compromised Tax expression and
HTLV-1 transcription. LKB1 and SIKs function as host
restriction factors that counteract Tax activation of
HTLV-1 long terminal repeats. Expression of LKB1 and
activated SIKs effectively blunted Tax activity in a phos-
phorylation-dependent manner in LKB1-null HeLa cells,
whereas compromising these kinases, but not AMP-
dependent protein kinases, augmented Tax function in
LKB1-proficient HEK293T cells. Activated LKB1 and
SIKs associated with Tax. Enforced expression of LKB1
or SIK1 in pX1MT-transfected cells and HTLV-1-trans-
formed ATL cells repressed proviral transcription,
whereas depletion of LKB1 boosted Tax expression.
Taken together, our findings revealed a potential
therapeutic and prophylactic agent for ATL as well as a
new negative regulatory function of LKB1 and SIKs in
HTLV-1 transcription. (Supported by HKU7661/08M,
HKU7674/12M, HKU1/CRF/11G and SKY-MRF-2011).
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